{"task_id": "49bc0a3258c89e29", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 387/464)", "text": "CAL FEATURES\nDementia and Cognitive Impairment\n379\n\n--- Page 401 ---\nDIAGNOSTIC ISSUES (CONT\u2019D)\n\u0003\nUTILITY\nif score <4, likely Alzheimer\u2019s disease; if\n>7, likely vascular dementia\nCLOCK DRAWING\na test of constructional apraxia\nwith many technical variants. Wolf Klein method\nprovides patient with paper and preprinted circle (4\nin. in diameter) and instructions to \u2018\u2018draw a clock.\u2019\u2019\n\u2018\u2018Normal\u2019\u2019 clock has numbers clockwise in correct\norder and near rim, even without hands on clock.\nAbnormal clock drawing argues for dementia (LR+\n5.3). Normal clock drawing not useful (as half of\ndemented patients can produce normal clock)\nCRITERIA FOR PERFORMING CT HEAD\nage <60,\nrapid (1 2 months) unexplained decline in cognition\nor function, dementia of short duration (<2 years),\nunexplained neurological symptoms (e.g. new onset\nheadache or seizures), early incontinence/gait disor\nder (NPH), recent head trauma, history of cancer, use\nof anticoagulants or history of bleeding disorder, new\nlocalizing signs, unusual or atypical cognitive symp\ntoms or presentation (e.g. progressive aphasia)\nCMAJ 1999 160:12; Canadian Consensus\nConference on Dementia\nMANAGEMENT\nRISK REDUCTION\nanti hypertensive (see HYPER\nTENSION p. 57), dyslipidemia treatment (see DYSLI\nPIDEMIA p. 62)\nDISEASE MANAGEMENT\nanticholinesterase may\nbe considered for Alzheimer\u2019s disease and include\ndonepezil 5 10 mg PO qhs, rivastigmine 1.5 6 mg\nPO BID, and galantamine ER 8 24 mg daily. Avoid if\nseizures, cardiac conduction problems, significant\nasthma, COPD, or recent GI bleed. Memantine\n5 10 mg PO BID may be used as a single agent or\nas add on therapy to cholinesterase inhibitor\nSYMPTOM MANAGEMENT\ntreat problem beha\nviors with non pharmacological and pharmacological\napproaches (trazodone, atypical antipsychotics). Treat\nco existing depression\nTUBE FEEDING\ngenerally not recommended for\nadvanced dementia because of increased complica\ntions without evidence of clinical benefit (e.g.\nMANAGEMENT (CONT\u2019D)\nsurvival, quality of life, prevention of aspiration pneu\nmonia, reduction of pressure sores or infections, func\ntional improvement)\nSPECIFIC ENTITIES\nSEQUENCE OF SYMPTOMS IN ALZHEIMER\u2019S DIS\nEASE\nmood changes, cognitive decline, loss of\nfunctional autonomy, neuropsychiatric manifesta\ntions, parkinsonism\nLESS COMMON CAUSES OF DEMENTIA\n\u0003\nNORMAL PRESSURE HYDROCEPHALUS (NPH)\n\u0003\nPATHOPHYSIOLOGY\ninflammation and fibrosis\nof the arachnoid granulations ! decreased\nabsorption of CSF ! hydrocephalus ! normal\nopening pressure but elevated pressure over\nperiventricular white matter tracts\n\u0003\nCAUSES\nidiopathic or secondary, e.g. subarach\nnoid hemorrhage, chronic meningitis\n\u0003\nCLINICAL FEATURES\nclassic triad of gait apraxia\n(magnetic gait as feet are stuck to floor), urge\nincontinence, and cognitive decline. Also may\nhave postural instability, lower extremity spasti\ncity, hyperreflexia, and extensor plantar responses\n\u0003\nDIAGNOSIS\nclinical diagnosis and MRI. Improve\nment of gait or cognition 1 h after removal of\n30 50mLofCSFcanbehelpfulfordiagnosis(Fisher\ntest,PPV90 100%,NPV30 50%).Animprovement\nalso predicts responsiveness to shunting\n\u0003\nTREATMENTS\nlumbar puncture, shunts (ventricu\nloperitoneal, ventriculoatrial, lumboperitoneal)\n\u0003 PARKINSON\u2019S-PLUS\nSYNDROMES\ninclude progres\nsive supranuclear palsy, multiple system atrophy\nand corticobasal ganglionic degeneration\n\u0003\nCREUTZFELDT\u2013JAKOB\nDISEASE\nrapid progression,\ncharacteristic EEG, myoclonic jerks, and expected\ndeath in 6 12 months\n\u0003\nHUNTINGTON\u2019S\nDEMENTIA\nautosomal\ndominant\nwith incomplete penetrance; premorbid DNA test\ning quantifies risk, severity, and age of onset\n\u0003\nCORTICONUCLEAR DEGENERATION\nmarked visual\nspatial impairment, substantial apraxia, but mem\nory impairment less noticeable\nDelirium\nNEJM 2006 354:11\nDIFFERENTIAL DIAGNOSIS\nwDIMSw\nDRUGS wABCDw\n\u0003 ALCOHOL\nintoxication, withdrawal, Wernicke\nKorsakoff\n\u0003 ANTICHOLINERGICS\natropine,\nbenztropine,\nscopolamine\n\u0003 ANTIDEPRESSANTS\nSSRIs, TCA\nDIFFERENTIAL DIAGNOSIS (CONT\u2019D)\n\u0003 ANTICONVULSANTS\ncarbamazepine, phenytoin,\nvalproate, phenobarbital\n\u0003 ANALGESICS\nopioids, NSAIDs, steroids\n\u0003 ANTIBIOTICS\npenicillins, quinolones, sulfona\nmides,\nisoniazid,\nrifampin,\nstreptomycin,\nchloroquine, acyclovir\n\u0003 ANTI-HISTAMINES\ncimetidine,\nfamotidine,\nranitidine\n380\nDelirium", "text_length": 4237, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 387/464)", "type": "chunk", "chunk_index": 386, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.782301", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.782990", "status": "pending"}